DNA Vaccines: Methods and Protocols

529 Pages·2000·3.691 MB·English

by  Anthony P. Green (auth.), Douglas B. Lowrie MD, Robert G. Whalen MD (eds.)

DNA Vaccines
M E T H O DS IN M O L E C U L AR M E D I C I N E ""
John M. Walker, SERIES EDITOR
46. Angiogenesis: Reviews and 34. Rotavtrus Methods and Protocols,
Protocols, edited by./. Clifford edited by James Gray and Ulrich
Murray, 2000 Desselberger, 2000
33. Cytomegalovirus Protocols, edited
45. Hepatocellular Carcinoma Methods
by John Sinclair, 2000
and Protocols, edited by Nagy A.
32. Alzheimer's Disease: Methods and
Habib, 2000
Protocols, edited by Nigel M. Hooper, 1999
44. Asthma: Mechanisms and Protocols,
31. Hemostasis and Thrombosis
edited by K. Fan Chung and Ian
Protocols: Methods in Molecular
Adcock, 2000
Medicine, edited by David J. Perry
43. Muscular Dystrophy: Methods and and K. John Past, 1999
Protocols, edited by Katherine B.
30. Vascular Disease: Molecular Biology
Bushby and Louise Anderson, 2000
and Gene Therapy Protocols, edited
42. Vaccine Adjuvants: Preparation by Andrew H. Baker, 1999
Methods and Research Protocols,
29. DNA Vaccines: Methods and
edited by Derek T. O 'Hagan, 2000
Protocols, edited by Douglas B.
41. Celiac Disease: Methods and Lowrie and Robert Whalen, 1999
Protocols, edited by Michael N.
Marsh, 2000 28. Cytotoxic Drug Resistance
Mechanisms, edited by Robert Brown
40. Diagnostic and Therapeutic
and Uta Boger-Brown, 1999
Antibodies, edited by Andrew J. T.
George and Catherine E. Urch, 2000
27. Clinical Applications of Capillary
39. Ovarian Cancer: Methods and Electrophoresis, edited by Stephen
Protocols, edited by John M. S. M. Palfrey, 1999
Bartlett, 2000
26. Quantitative PCR Protocols, edited
38. Aging Methods and Protocols, by Bernd Kochanowski and Udo
edited by Yvonne A. Barnett and Reischl, 1999
Christopher P. Barnett, 2000 25. Drug Targeting, edited by G. E.
37. Electrically Mediated Delivery of Francis and Cristina Delgado, 1999
Molecules to Cells, edited by Mark J. 24. Antiviral Methods and Protocols,
Jaroszeski, Richard Heller, and edited by Derek Kinchington
Richard Gilbert, 2000 and Raymond F. Schinazi, 2000
36. Septic Shock Methods and Protocols, 23. Peptidomimetics Protocols, edited by
edited by Thomas J. Evans, 2000 Wieslaw M. Kazmierski, 1999
35. Gene Therapy of Cancer: Methods 22. Meurodegeneration Methods and
and Protocols, edited by Wolfgang Protocols, edited by Jean Harry
Walther and Ulrike Stein, 2000 and Hugh A. Tilson, 1999
M E T H O D S I N M O L E C U L A R M E D I C I N ETM
DNA Vaccines
Methods and Protocols
Edited by
Douglas B. Lowrie,
MD
Mycobacterial Research Laboratory, London, UK
and
Robert G. Whalen,
MD
Maxygen Inc., Redwood City, CA
Humana Press Totowa, New Jersey
© 2000 Humana Press Inc.
999 Riverview Drive, Suite 208
Totowa, New Jersey 07512
All rights reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted in
any form or by any means, electronic, mechanical, photocopying, microfilming, recording, or otherwise
without written permission from the Publisher. Methods in Molecular Medicine™is a trademark of The
Humana Press Inc.
All authored papers, comments, opinions, conclusions, or recommendations are those of the author(s), and
do not necessarily reflect the views of the publisher.
This publication is printed on acid-free paper. ∞
ANSI Z39.48-1984 (American Standards Institute) Permanence of Paper for Printed Library Materials.
Cover design by Patricia F. Cleary.
For additional copies, pricing for bulk purchases, and/or information about other Humana titles, contact
Humana at the above address or at any of the following numbers: Tel.: [phone]; Fax: [phone];
E-mail: [email protected]; Website: http://humanapress.com
Photocopy Authorization Policy:
Authorization to photocopy items for internal or personal use, or the internal or personal use of specific
clients, is granted by Humana Press Inc., provided that the base fee of US $10.00 per copy, plus US $00.25
per page, is paid directly to the Copyright Clearance Center at 222 Rosewood Drive, Danvers, MA 01923.
For those organizations that have been granted a photocopy license from the CCC, a separate system of
payment has been arranged and is acceptable to Humana Press Inc. The fee code for users of the Transactional
Reporting Service is: E0-89603-580-8/99 $10.00 + $00.25].
Printed in the United States of America. 10 9 8 7 6 5 4 3 2 1
Library of Congress Cataloging in Publication Data
Main entry under title:
Methods in molecular medicine™.
DNA vaccines : methods and protocols / edited by Douglas B. Lowrie and Robert G. Whalen.
p. cm. — (Methods in molecular medicine™ ; 29)
Includes bibliographical references and index.
ISBN 0-89603-580-8 ( alk. paper).
1. DNA vaccines—Research—Methodology. I. Lowrie, Douglas B. II. Whalen, Robert G.
III. Series.
QR189.5.D53D63 1999
615'.372--DC21 98-55325
CIP
Preface
The field of DNA vaccines has undergone explosive growth in the last
few years. As usual, some historical precursors of this approach can be dis-
cerned in the scientific literature of the last decades. However, the present
state of affairs appears to date from observations made discreetly in 1988 by
Wolff, Malone, Felgner, and colleagues, which were described in a 1989 patent
and published in 1990. Quite surprisingly, they showed that genes carried by
pure plasmid DNA and injected in a saline solution, hence the epithet “naked
DNA,” could be taken up and expressed by skeletal muscle cells with a low
but reproducible frequency. Such a simple methodology was sure to spawn
many applications. In a separate and important line of experimentation, Tang,
De Vit, and Johnston announced in 1992 that it was indeed possible to obtain
humoral immune responses against proteins encoded by DNA delivered to the
skin by a biolistic device, which has colloquially become known as the “gene
gun.”
The year 1993 saw the publication of further improvements in the meth-
ods of naked DNA delivery and, above all, the first demonstrations by several
groups of the induction of humoral and cytotoxic immune responses to viral
antigens expressed from injected plasmid DNA. In some cases, protection
against challenge with the pathogen was obtained. The latter result was un-
questionably the touchstone of a method of vaccination worthy of the name.
DNA or “genetic” vaccination (or, as the World Health Organization
suggested,“nucleic acid vaccination) was now really and truly delivered unto
the scientific world. In 1995 Bernard Dixon, Contributing Editor for Bio/Tech-
nology(nowNature Biotechnology), called this development the “Third Vac-
cine Revolution.” Some were less fervent believers, gravely reminding naïve
molecular biologists that it was assuredly not safe to inject DNA. They added
that DNA-based immunization was, après tout, only a technique, barren of
any intrinsic scientific interest. Such reactions are not unknown in the history
of science, although subsequent events appear to lend little support to this
idiosyncratic point of view.
Only a dozen or so publications on DNA vaccines appeared in 1993, and
less than 100 in all of 1995. The numbers have increased steadily and now
exceed 900 in total (June 1999). This rapid increase stems partly from the fact
v
vi Preface
that DNA-based immunization in experimental models is a relatively easy
methodology to implement. Indeed, the technical barriers to entry in this field
are so low that scientists in countries all over the world can readily begin to
study prototype vaccines to diseases that are of particular interest to their re-
gion of the globe.
This is a most salutary development since infectious agents know no
national boundaries. In contrast many diseases of the developing world often
receive scant notice from the large commercial entities in developed coun-
tries. A firm belief in the global utility of vaccination and the general useful-
ness of DNA vaccine methodology prompted one of us to create, in 1995, an
Internet site called The DNA Vaccine Web. This protean publication takes
advantage of the World Wide Web to promulgate information on new and
important developments.
In what might well be record time, DNA vaccines entered clinical trials
in mid-1995. Today, four years later, we have been assured of at least the
minimum level of safety for DNA vaccines when injected into humans, but
we are by and large still waiting for reports on the efficacy of the first trials. It
is still early days in the clinic. Doubtless, “naked” DNA vaccination will not
be the instantly successful panacea that one might have hoped for. Other for-
mulations of plasmid DNA will probably be required to ensure the reproduc-
ibility and efficacy of DNA-mediated vaccination in real-world settings.
DNA vaccination is a simple methodology. There are only so many ways
to explain how to inject a DNA-containing solution into muscle or skin. The
articles in this compendium, therefore, also provide detailed information on
the essentials of “upstream” and “downstream” analysis. The safety aspects,
quality control, and preparation of plasmid DNA will be of primary impor-
tance for those contemplating clinical trials for human or veterinary applica-
tions of DNA vaccines. Several authors discuss the use of classical adjuvants,
“genetic adjuvants” (involving coexpression of cytokines), and the
immunostimulatory properties of DNA or certain oligonucleotide sequences.
Details on formulations of DNA and some novel expression systems provide
extensions of the standard methodology that might prove highly beneficial in
the long run. With respect to DNA vaccines being “just” a technique, several
contributors provide strategic ideas on antigen engineering and describe some
of the particularly novel applications of DNA vaccine methodology that have
already been devised. The simplicity of experimental methods allows human
creativity to come to the fore in surprising ways.
Finally, we felt that it was essential to devote consideration to the topic
of dendritic cells, and antigen-presenting cells generally, which are the major
Preface vii
players in the aptitude of DNA vaccines to activate the immune system. As
Sigmund Freud said of the role of dream content in understanding the uncon-
scious, the injection of plasmid DNA might serendipitously provide us with
the “royal road” to greater comprehension of dendritic cell function. If so,
DNA vaccines hold great promise for influencing the immune response.
We are pleased to have secured for Humana Press an impressive list of
contributors whose expertise in various areas of DNA vaccines, immunology,
and related disciplines is without question. The Editors thank Prof. John Walker,
Series Editor, and Mr. Thomas Lanigan, President of Humana Press, for their
foresight, support, and assistance in the realization of this volume.
Douglas B. Lowrie, MD
Robert G. Whalen, MD
Contents
Preface .............................................................................................................v
Contributors...................................................................................................xiii
1 Purification of Supercoiled Plasmid
Anthony P. Green..................................................................................1
2 Production of Plasmid DNA in Industrial Quantities According to
cGMP Guidelines
Joachim Schorr, Peter Moritz, and Martin Schleef.........................11
3 Development and Characterization of Lyophilized DNA Vaccine
Formulations
Nancy L. Shen, Jukka Hartikka, Nancy A. Horn,
Marston Manthorpe, and Magda Marquet....................................23
4 Repeated Use of Qiagen Columns in Large-Scale Preparation
of Plasmid DNA
Derek Gregory, Ricardo E. Tascon, and Douglas B. Lowrie..........35
5 The Immunology of DNA Vaccines
Thomas Tüting, Jonathan Austyn, Walter J. Storkus, and
Louis D. Falo Jr..............................................................................37
6 Methodology Used in DNA-Based Prophylactic and Therapeutic
Immunization Against Hepatitis B Virus in Chimpanzees
Alfred M. Prince and Betsy Brotman.................................................65
7 Intramuscular and Intradermal Injection of DNA Vaccines
in Mice and Primates
Heather L. Davis...................................................................................71
8 Veterinary DNA Vaccines
Sylvia van Drunen Littel-van den Hurk, Ralph P. Braun,
and Lorne A. Babiuk.......................................................................79
9 DNA-Based Immunization of Neonatal Mice
Cynthia L. Brazolot Millan and Heather L. Davis.............................95
10 Intramuscular Injection of DNA Vaccines in Fish
Joël Heppell and Heather L. Davis....................................................99
11 Development of DNA Vaccines for Salmonid Fish
Eric D. Anderson and Jo-Ann C. Leong.........................................105
ix
x Contents
12 CTL Analysis for Tumor Vaccines
Antonio Rosato, Gabriella Milan, Annalisa Zambon,
Paola Zanovello, and Dino Collavo.............................................123
13 The Use of Bone Marrow-Chimeric Mice in Determining the MHC
Restriction of Epitope-Specific Cytotoxic T Lymphocytes
Akiko Iwasaki and Brian H. Barber..................................................133
14 Immunostimulatory DNA Sequences: An Overview
John H. Van Uden and Eyal Raz......................................................145
15 Immunostimulatory CpG Motifs and DNA Vaccines
Risini Weeratna, Arthur M. Krieg, and Heather L. Davis..............169
16 In Vitro Assay of Immunostimulatory Activities of Plasmid Vectors
Charles F. Reich and David S. Pisetsky.........................................173
17 Adjuvants for Plasmid DNA Vaccines
Jon Norman, Jukka Hartikka, Pamela Strauch,
and Marston Manthorpe...............................................................185
18 Cytokine and Costimulatory Factor-Encoding Plasmids as
Adjuvants for DNA Vaccination
Kenji Okuda, Susumu Kawamoto, and Jun Fukushima...............197
19 Optimization of DNA Vaccines Through the Use of
Molecular Adjuvants
Jong J. Kim and David B. Weiner....................................................205
20 Cytokine Fusion Constructs as DNA Vaccines Against Tumors
Holden T. Maecker, Athanasia Syrengelas, and Ronald Levy.....221
21 The Use of Conventional Immunologic Adjuvants in DNA Vaccine
Preparations
Shin Sasaki and Kenji Okuda...........................................................241
22 Genetic Adjuvants
Hildegund C. J. Ertl, Susanna Pasquini, Zhenning He,
Hongying Deng, Louise Showe, Wynetta Giles-Davis,
Yijie Wang, InSug O, Hilary Marston,
Magdalena Blaszczyk-Thurin, and Zhiquan Xiang....................251
23 DNA Immunization in Combination with the Immunostimulant
Monophosphoryl Lipid A
Donald L. Lodmell, Nancy B. Ray, and Larry C. Ewalt.................261
24 Controlled Plasmid Delivery and Gene Expression: Applications
for Nucleic Acid-Based Vaccines
Russell J. Mumper, Harry C. Ledebur, Jr., Alain P. Rolland,
and Eric Tomlinson.......................................................................267
Contents xi
25 Mucosal Immunization with DNA Vaccines
Michael J. McCluskie and Heather L. Davis...................................287
26 Preparations for Particle-Mediated Gene Transfer Using the
Accell®Gene Gun
Michael D. Macklin, Robert J. Drape, and William F. Swain........297
27 Entrapment of Plasmid DNA Vaccines into Liposomes by
Dehydration/Rehydration
Gregory Gregoriadis, Brenda McCormack, Mia Obrenovich,
and Yvonne Perrie.........................................................................305
28 DNA-Based Vaccination with Polycistronic Expression Plasmids
Reinhold Schirmbeck, Jan von Kampen, Karin Metzger,
Jens Wild, Beate Grüner, Martin Schleef, Andrea Kröger,
Hansjörg Hauser, and Jörg Reimann.........................................313
29 A Nonviral Cytoplasmic T7 Autogene System and Its Applications
in DNA Vaccination
Franck G. Sturtz, Yunsheng Li, Janine Shulok,
H. Ralph Snodgrass, and Xiao-zhuo Chen.................................323
30 Immunization with Naked DNA Coexpressing Antigen and Cytokine
via IRES
Jochen Heinrich, Bettina Strack, Michael Nawrath,
Jovan Pavlovic, and Karin Moelling..........................................335
31 Genetic Subunit Vaccines: A Novel Approach for
Genetic Immunization
I. Frank Ciernik and David P. Carbone............................................345
32 Antigen Engineering in DNA Immunization
Shan Lu, Steve Manning, and James Arthos.............................355
33 Genetic Vaccination Targeting T-Cell Receptors
Alexis P. Godillot, Qiong Fang, Terry Higgins,
Catherine J. Pachuk, Jean Boyer, David B. Weiner,
Stuart Lessin, and William V. Williams.......................................375
34 Immunity to T-Cell Receptor: Suppressive Vaccination with DNA
Encoding a Variable Region Gene of the T-Cell Receptor
Ari Waisman.......................................................................................397
35 DNA Fusion Vaccines Against B-Cell Tumors
Delin Zhu, Myfanwy B. Spellerberg, Catherine A. King,
Jason Rice, Andrew R. Thompsett,
and Freda K. Stevenson...............................................................405
36 DNA-Based Vaccination Primes Tumor-Rejecting T-Cell Responses
Waltraud Böhm, Martin Schleef, Stefan Thoma,
Reinhold Schirmbeck, and Jörg Reimann.................................425